JOINN Clinical Testing and Hangzhou Newland Technology Strategic Cooperation to Lead the Innovation of Neurological Disease Detection Technology

On February 26, 2025, the international leading clinical testing organization "JOINN Clinical Testing" signed a strategic cooperation agreement with Hangzhou Newland Technology.®) technology, focusing on biomarker research for neurodegenerative and Neuroimmune Diseases, accelerating drug development and clinical application,Provide full chain solutions for global pharmaceutical customers.

Prev: JOINN was awarded "the sixth batch of industrial technology basic public service platform of the Ministry of Industry and Information Technology" Next: JOINN Invited to Attend the Launch Meeting of National Molecular Drug Innovation Center